THE ULTIMATE GUIDE TO PHARMACEUTICAL INGREDIENTS

“The existing problem has exposed some structural weaknesses from the EU’s medicines offer chain plus a substantial dependence on non-EU international locations for active pharmaceutical ingredients,” Kyriakides mentioned. She advised that offer chain concerns be resolved within an EU pharmaceutical strategy envisioned for being released by t